CHI3L1 and colitis: In view of the clear biological activity of SPS in alleviating intestinal inflammation, regulating immune-related pathways and targeting CHI3L1 in the treatment of Colitis, it can provide a direct and reliable scientific basis for the subsequent development of functional foods using SPSs as a core functional component.